Post
Pfizer leads first-in-human trials
First-in-human trials are the initial stage of human clinical trials for a new drug or treatment. These trials involve testing …
UK poll points to diversity as crucial point for clinical trial trust
A UK poll has found that 88% of respondents believe that it is important that health and social care trials …
Emirati oil casts an inescapable shadow over climate talks at COP28
DUBAI - For people in the climate world, the annual two-week extravaganza that is COP28 is a moment to see …
Mission obtains MHRA authorisation for Parkinson’s disease trial
UK-based Mission Therapeutics has obtained clinical trial authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to assess …
CTO Europe 2023: A snapshot of challenges and opportunities in oncology
Global developments and old challenges clash with the arrival of new technologies for drug development in oncology, creating both opportunities …
Roche reports positive Phase III data for breast cancer therapy
Swiss pharmaceutical company Roche has reported positive data from the Phase III INAVO120 clinical trial of its investigational therapy, inavolisib, …
Alto touts success of EEG biomarker in Phase II MDD trial
Alto Neuroscience reported positive results on a predictive biomarker and efficacy of ALTO-300 in a Phase II trial in patients …
Technoderma concludes Phase I trial of atopic dermatitis drug
Chinese biopharmaceutical company Technoderma Medicines has concluded a Phase I clinical trial of TDM-180935 topical ointment for the treatment of …
EyePoint reports positive data from trial of wet AMD therapy
US-based pharmaceutical company EyePoint Pharmaceuticals has reported positive topline data from the Phase II DAVIO 2 clinical trial of its …
Viriom outlines plans for upcoming infectious disease trials
Viriom plans to extend a Phase I trial investigating its influenza pill AV5124, according to chief science officer Dr David …
Exelixis and Arcus to analyse zanzalintinib and AB521 in trial
US-based biotechnology company Exelixis has signed a clinical trial collaboration agreement with Arcus Biosciences to analyse zanzalintinib along with AB521 …
Pharma industry groups push initiatives against climate change at COP28
Several pharmaceutical industry advocacy and lobby organisations have bandied together to release a joint industry statement supporting the Declaration on …
Everest inches towards clinical studies for renal disease drug in China
Everest Medicines is on track to commence clinical trials in China for its renal disease drug candidate, following the acceptance …
Daré Bioscience launches Phase III hormone-free contraceptive trial
US biopharma firm Daré Bioscience has started a Phase III trial investigating the effectiveness and safety of Ovaprene, a hormone-free …
Signal: Absci and AstraZeneca sign deal on AI-powered cancer antibody drug
Pharmaceuticals giant AstraZeneca has closed on a deal with US-based biotech Absci Corporation to develop an antibody therapy for an …